Xinyi Yu

Xinyi Yu


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2025 in European Journal of Medical Research
Verified
Journal Article
Open access
PDF file
XYXinyi Yu
Xinyi Yu
ZFZean Fu
Zean Fu
MYMinghuan Yu
Minghuan Yu
YSYibo Shi
Yibo Shi
To investigate the association between Lp(a) levels and calcific aortic valve disease (CAVD) and the potential molecular mechanism underlying the effect of LPA gene expression on aortic valve calcification (AVC). Case–control and cohort studies on the association between Lp(a) and CAVD were searched in the meta-analysis. Meta-analysis was performed using RevMan and Stata. AVC-related gene microarray data were obtained from the GEO database. The Gene Set Variation Analysis (GSVA) algorithm was used to synthetically score each gene set and analyze differences in pathways in the LPA gene high- and low-expression groups. The expression of endothelial markers, interstitial markers and osteogenic markers after Lp(a) intervention in human aortic valve endothelial cells (AVEC) was detected by Western blot. The risk of CAVD was increased 1.44-fold (95% CI 1.25–1.67, P < 0.05) when Lp(a) concentrations were > 30 mg/dL and 1.95-fold (95% CI 1.93–1.97, P < 0.05) when Lp(a) concentrations were > 50 mg/dL. GSVA results showed that high expression of the LPA gene was associated with TGF-β signaling, oxidative phosphorylation, and reactive oxygen species pathway. Western-blot results showed that after Lp(a) was co-cultured with AVEC for 72 h, the expression of endothelial markers decreased, while the expression of interstitial markers and osteogenic markers increased. Elevated Lp(a) concentration is a risk factor for CAVD. High expression of the LPA gene (or high concentration of Lp(a)) may cause EndoMT of AVEC by disrupting pathways, such as TGF-β signaling, resulting in CAVD.

21 March 2023 in Heliyon
Verified
Journal Article
Open access
RZRen-Jian-Zhi Zhang
Ren-Jian-Zhi Zhang
XYXinyi Yu
Xinyi Yu
JWJing Wang
Jing Wang
JLJian Lv
Jian Lv
YZYan Zheng
Yan Zheng
ZLZhi-Gang Liu
Zhi-Gang Liu
Developing and assessing a risk prediction model of postoperative atrial fibrillation (POAF) after coronary artery bypass grafting (CABG), and aims to provide a reference for the prediction and prevention. A retrospective case-control study. Three major urban teaching and university hospitals and tertiary referral centers. consecutive patients undergoing CABG. The study was retrospective and no interventions were administered to patients. In the study, the overall new-onset POAF prevalence was approximately 28%. A prediction model for POAF with nine significant indicators was developed, and identified new predictors of POAF: left ventricular end diastolic diameter (LVEDD), intraoperative defibrillation, and intraoperative temporary pacing lead implantation. The model had good discrimination in both the derivation and validation cohorts, with the area under the receiver operating characteristic curves (AUCs) of 0.621 (95% CI = 0.602-0.640) and 0.616 (95% CI = 0.579-0.651), respectively, and showed good calibration. Compared with CHA2DS2-VASc, HATCH score, and the prediction model of POAF after CABG developed based on a small sample of clinical data from a single center in China, the model in this study had better discrimination. We have developed and validated a new prediction model of POAF after CABG using multicenter data that can be used in the clinic for early identification of high-risk patients of POAF, and to help effectively prevent POAF in postoperative patients.

23 December 2022 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
MYMing-Huan Yu
Ming-Huan Yu
RZRen-Jian-Zhi Zhang
Ren-Jian-Zhi Zhang
XYXinyi Yu
Xinyi Yu
JSJian-Wei Shi
Jian-Wei Shi
Zhigang LiuZhigang Liu
Zhigang Liu
Objective: This study aims to analyze the association between preoperative LDL/HDL ratio and new-onset atrial fibrillation (AF) after on-pump coronary artery bypass grafting (on-pump CABG), evaluate the clinic value of preoperative LDL/HDL ratio to identify postoperative rhythm. Methods: A retrospective study of consecutive patients (n = 2052) who underwent on-pump CABG at TEDA International Cardiovascular Hospital (Tianjin, China), from June 1, 2020, to December 30, 2021, was conducted. The association between preoperative LDL/HDL and new-onset POAF was analyzed by Lowess curve and univariate logistic regression. The receiver operating characteristic curve (ROC) and area under the curve (AUC) were used to evaluate the identification capacity of preoperative LDL/HDL level for new-onset POAF. Results: In studied populations, the incidence of new-onset POAF was about 29.24%. The lowess curve showed that the association between preoperative LDL/HDL ratio and POAF after on-pump CABG was similar to a linear relationship. With the increasement of preoperative LDL/HDL ratio, the incidence of POAF increased simultaneously. ROC analysis showed that preoperative LDL/HDL ratio could identify postoperative arrhythmia after on-pump CABG (AUC = 0.569,95% CI = 0.529–0.608, P = 0.006) among female patients, the best preoperative LDL/HDL ratio cutoff of 2.11, which was considered a predictive factor of incident POAF, showed a sensitivity of 83.60% (95% CI = 0.775–0.886) and a specificity of 30.02% (95% CI = 0.257–0.346). Conclusion: Preoperative LDL/HDL ratio is associated with new-onset POAF, but there is a difference in different sex. Preoperative LDL/HDL level can help to identify postoperative rhythm in females.

3 March 2022 in Artificial Organs
Verified
Journal Article
Open access
PDF file
XYXinyi Yu
Xinyi Yu
JSJian‐Wei Shi
Jian‐Wei Shi
YZYi‐Rui Zang
Yi‐Rui Zang
JZJie‐Min Zhang
Jie‐Min Zhang
Zhigang LiuZhigang Liu
Zhigang Liu
Objectives: An acute animal experiment was performed to observe factors influencing the functional status of the aortic valve functional status after continuous‐flow left ventricular assist device (CF‐LVAD) implantation in an ovine model, and a physiologic predictive model was established.Methods: A CF‐LVAD model was established in Small Tail Han sheep. The initial heart rate (HR) was set to 60 beats/min, and grouping was performed at an interval of 20 beats/min. In all groups, the pump speed was started from 2000 rpm and was gradually increased by 50–100 rpm. A multi‐channel physiological recorder recorded the HR, aortic pressure, central venous pressure, and left ventricular systolic pressure (LVSP). A double‐channel ultrasonic flowmeter was used to obtain real‐time artificial vascular blood flow (ABF). A color Doppler ultrasound device was applied to assess the aortic valve functional status. Multivariate dichotomous logistic regression was used to screen significant variables for predicting the functional status of the aortic valve.Results: Observational studies showed that ABF and the risk of aortic valve closure (AVC) were positively correlated with pump speed at the same HR. Meanwhile, the mean arterial pressure (MAP) was unaltered or slightly increased with increased pump speed. When the pump speed was constant, an increase in HR was associated with a decrease in the size of the aortic valve opening. This phenomenon was accompanied by an initial transient increase in the ABF and MAP, which subsequently decreased. Statistical analysis showed that the AVC was associated with increased pump speed (OR = 1.02, 95% CI = 1.01–1.04, p = 0.001), decreased LVSP (OR = 0.95, 95% CI = 0.91–0.98, p = 0.003), and decreased pulse pressure (OR = 0.82, 95% CI = 0.68–0.96, p = 0.026). ABF or MAP was negatively associated with the risk of AVC (OR < 1). The prediction model of AVC after CF‐LVAD implantation exhibited good differentiation (AUC = 0.973, 95% CI = 0.978–0.995) and calibration performance (Hosmer–Lemeshow χ2 = 9.834, p = 0.277 > 0.05).Conclusions: The pump speed, LVSP, ABF, MAP, and pulse pressure are significant predictors of the risk of AVC. Predictive models built from these predictors yielded good performance in differentiating aortic valve opening and closure after CF‐LVAD implantation.

12 August 2025 in Natural Product Research
Verified
Journal Article
Closed access
XYXinyi Yu
Xinyi Yu
YSYibo Shi
Yibo Shi
MXMingjie Xie
Mingjie Xie
JZJingchao Zhang
Jingchao Zhang
Abnormal activation of the TGF-β signalling pathway is implicated in various diseases, making it a promising therapeutic target. Among potential inhibitors, natural compounds have attracted significant attention due to their structural diversity, multitarget activity and favourable safety profiles. However, a comprehensive review of the field and an analysis of current research hotspots remain limited. This study utilises bibliometric analysis and knowledge mapping to examine natural compound inhibitors of the TGF-β signalling pathway, assessing their developmental trajectory, evolutionary trends and research priorities. Additionally, a detailed review of research hotspots explores the therapeutic potential, mechanisms of action and limitations of key compounds. These findings aim to guide future research and support the clinical translation of natural compound inhibitors targeting the TGF-β signalling pathway.

3 September 2024 in Nanomedicine
Verified
Journal Article
Open access
YSYibo Shi
Yibo Shi
ZFZean Fu
Zean Fu
XYXinyi Yu
Xinyi Yu
YZYuanfeng zhang
Yuanfeng zhang
GFGuangrui Fan
Guangrui Fan
ZWZhiping Wang
Zhiping Wang
Aim: We conducted a bibliometric analysis to quantitatively study the development pathway, research hotspots and evolutionary trends of nano-drug delivery systems (NDDS) in treating urological tumors. Materials & methods: We used the Web of Science Core Collection to retrieve the literature related to NDDS in the urological tumors up to November 1, 2023. Bibliometric analysis and visualization were conducted using CiteSpace, VOSviewer and R-Bibliometrix. The major aspects of analysis included contributions from different countries/regions, authors' contributions, keywords identification, citation frequencies and overall research trends. Results: We included 3,220 articles. The analysis of annual publication trends revealed significant growth in this field since 2010, which has continued to the present day. The United States and China have far exceeded other countries/regions in the publication volume of papers in this field. The progression of the shell structure of NDDS in the urinary system has gradually transitioned from non-biological materials to biocompatible materials and ultimately to completely biocompatible materials. Mucoadhesive NDDS for intravesical drug delivery is a hotspot and a potential research material for bladder cancer. Conclusion: The field of NDDS in urological tumors has emerged as a research hotspot. Future research should focus on synergistic effects of NDDS with other treatment modalities.